|
CN106822142A
|
|
The benzimidazolyl and morpholinyl-derivatives composition of Atropurpuran are used for anti-hepatic fibrosis
|
|
CN106822141A
|
|
The benzimidazolyl and morpholinyl-derivatives composition of Atropurpuran are used for anti-inflammatory
|
|
CN106822072A
|
|
The derivative composition of Atropurpuran is used for anti-inflammatory
|
|
CN106822140A
|
|
The benzimidazolyl and morpholinyl-derivatives composition of Atropurpuran are used to prevent and treat kidney fibrosis
|
|
CN106822102A
|
|
The imidazole radicals and bischloroethylamines radical derivative composition of Atropurpuran are used for anti-acute gout
|
|
CN106822131A
|
|
The piperazinyl of Atropurpuran and two hydroxyethylamine derivative compositions are used for anti-inflammatory
|
|
CN106822130A
|
|
The piperazinyl of Atropurpuran and two hydroxyethylamine derivative compositions are used for anti anoxia
|
|
CN106822132A
|
|
The piperazinyl of Atropurpuran and two hydroxyethylamine derivative compositions are used to prevent and treat pancreatic fibrosis
|
|
CN106420719A
|
|
Applications of composition of Atropurpuran derivatives in preparing medicines for preventing or treating pancreatic fibrosis
|
|
CN106420714A
|
|
Application of Atropurpuran derivative composition in low-erythrocyte anemia resistant drugs
|
|
CN106420725A
|
|
Applications of Atropurpuran derivative composition in antivirus drugs
|
|
CN106420723A
|
|
Application of Atropurpuran derivative composition in anti-inflammation drugs
|
|
CN106420720A
|
|
Application of atropurpuran derivative composition to medicines for increasing white blood cells
|
|
CN106420724A
|
|
Application of Atropurpuran derivative composition in preparation of medicine for resisting chronic obstructive pulmonary disease
|
|
CN106420713A
|
|
Application of Atropurpuran derivative composition in anti-rhinitis drugs
|
|
CN106420718A
|
|
Application of Atropurpuran derivative composition in anti-heart failure drugs
|
|
CN106176726A
|
|
The application in antibacterials of the Atropurpuran derivative composition
|
|
CN106420721A
|
|
Application of Atropurpuran derivative composition in anti-acute gout drugs
|
|
CN106420722A
|
|
Application of Atropurpuran derivative composition in preparing drugs for preventing and treating liver injury
|
|
CN105902550A
|
|
Application of composition of Virosaine A pyrrolidinyl and morpholinyl derivatives in drugs for treating or preventing renal fibrosis
|
